Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations
Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds
Chemo Combinations Tested In Phase III For Lung Cancer
Zometa Better Than Placebo In Treatment Of Bone Mets
NCI-Approved Clinical Trials
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO